Foxo1

Forkhead box O1 (FOXO1) modulators relate to transcriptional control of metabolism and stress responses. FOXO1 activity depends in part on its movement between the nucleus and cytoplasm, linking cellular signals to gene expression. AS1842856, AS1708727 and JY-2 are listed as FOXO1 inhibitors. LOM612 is annotated as a forkhead box O protein relocator, representing a different type of modulation. This selection spans compounds for examining transcription factor activity and localization in metabolic and cellular signaling research.

4 Items

  • AS1842856
    Cat. No.
    A15871

    AS1842856

    AS1842856 is a cell-permeable inhibitor that blocks the transcription activity of Foxo1 with IC50 of 33 nM. It could directly bind to the active Foxo1, but not the Ser256-phosphorylated form.

    5 mg
    $40.00
    10 mg
    $60.00
    All 7 sizes
  • AS1708727
    Cat. No.
    A39386

    AS1708727

    AS1708727 is an orally active inhibitor of Foxo1, exhibiting EC50 values of 0.33 μM for glucose-6-phosphatase (G6Pase) and 0.59 μM for phosphoenolpyruvate carboxykinase (PEPCK). This compound plays a significant role in modulating metabolic pathways and is valuable for research into glucose homeostasis and metabolic disorders. AS1708727 can be utilized in studies investigating the therapeutic potential of targeting Foxo1 in various diseases, including diabetes and cancer.

    5 mg
    $245.00
    10 mg
    $405.00
    All 5 sizes
  • JY-2
    Cat. No.
    A74862

    JY-2

    JY-2 is a selective inhibitor of the Forkhead box O1 (FoxO1) transcription factor, effectively inhibiting its transcriptional activity with an IC50 of 22 μM. This compound also exhibits moderate inhibitory effects on FoxO3a and FoxO4. JY-2 demonstrates notable anti-diabetic activity, making it a valuable tool for research related to metabolic disorders and the regulation of glucose homeostasis.

    5 mg
    $40.00
    10 mg
    $65.00
    All 5 sizes
  • FOXO1-IN-3
    Cat. No.
    A74863

    FOXO1-IN-3

    FOXO1-IN-3 is a selective inhibitor of FOXO1, a crucial transcription factor involved in glucose metabolism. This compound has demonstrated efficacy in reducing hepatic glucose production in murine models. Additionally, FOXO1-IN-3 enhances insulin sensitivity and improves glucose control in db/db mice, while not contributing to weight gain, making it a valuable tool for research on metabolic disorders and insulin resistance.

    5 mg
    $295.00
    10 mg
    $545.00
    All 5 sizes

4 Items

Added to your cart

View Cart Checkout

    Loading...